ITC Farma
ITC Farma is an Italian privately held CDMO in Pomezia that contract-manufactures solid and liquid oral pharmaceuticals, clinical trial (IMP) batches, and food supplements for pharmaceutical multinationals, Italian pharma companies, and nutraceutical brands under EU-GMP and AIFA authorization.
- Company typePrivate
- Founded1960
- HeadquartersPomezia, Italy
- Headcount51–100
- GTM typeB2B
- OfferingServices
What ITC Farma does
ITC Farma Srl is an Italian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Pomezia, south of Rome, within one of Italy's principal pharmaceutical clusters. Founded in the 1960s and operating as a privately held company since a 1996 management buyout from the Fisons Plc Group, ITC Farma runs a 12,000 sqm facility producing solid and liquid oral dosage forms (tablets, hard capsules, oral suspensions, solutions, drops, nasal sprays, sterilized inhalation liquids) plus food supplements, and is authorized to handle hormonal substances. The company is EU-GMP Volume 10 certified, AIFA-authorized for clinical trial (IMP) production, and Ministry-of-Health-authorized for food supplement packaging in a dedicated segregated area.
ITC Farma generates revenue through a portfolio of B2B services: full-cost turn-key contract manufacturing, intermediate supply of tablets and capsules, primary and secondary packaging, clinical trial (IMP) batch production, worldwide storage and distribution of medicinal products, vaccines and dietary supplements, and quality assurance/control services supported by a 250 sqm QC laboratory performing chemical, physical, and microbiological analysis under ICH guidelines. Its primary customer segments are pharmaceutical multinationals producing branded and generic medicines, Italian domestic pharmaceutical companies, food supplement manufacturers, and CROs/sponsors of clinical trials. Pricing is negotiated per project and is not publicly disclosed.
Technically, the facility runs an advanced equipment stack sourced primarily through a strategic partnership with IMA Active: the PREXIMA 300 high-speed tablet press (2.5 million micro-tablets per hour, 2018 Pharma Innovation Awards winner), ARIA 900 fluid bed system, ADAPTA 100 flexible capsule filler, GS 600 coating machine, and a 240-blister-per-minute packaging line with continuous printing, tamper-evident technology, and DataMatrix-based serialization for EU Falsified Medicines Directive compliance. A 2019 R&D laboratory and the €2.77M FESR-funded NU.C.FAR.NA/LIFE 2020 pilot granulation plant (built with Sapienza University of Rome) support process and method transfer. The company employs 51–100 people, invests in Lean manufacturing, and pursues regulated horizontal expansion into the nutraceutical vertical (announced 2022).
ITC Farma firmographics
Firmographics- Name
- ITC Farma
- Legal name
- ITC FARMA Srl
- Website
- https://itcfarma.it
- Company type
- Private
- Founded year
- 1960
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ITC Farma is an Italian privately held CDMO in Pomezia that contract-manufactures solid and liquid oral pharmaceuticals, clinical trial (IMP) batches, and food supplements for pharmaceutical multinationals, Italian pharma companies, and nutraceutical brands under EU-GMP and AIFA authorization.
- Ownership category
- akta.pro rank
ITC Farma industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where ITC Farma is headquartered
LocationHeadquarters
- HQ city
- Pomezia
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
ITC Farma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Contract Manufacturing - Full Cost (Turn-key): Complete pharmaceutical product manufacturing from raw materials to finished product, including all production steps and quality control. Full responsibility for the entire production process on behalf of clients.
- Intermediate Products Supply: Supply of stepping stones in the process such as tablets or capsules to pharmaceutical companies that complete manufacturing in-house.
- Primary and Secondary Packaging: Packaging services for pharmaceutical products including both primary packaging (blistering, bottling) and secondary packaging (cartoning, labeling).
- Food Supplements Secondary Packaging: Secondary packaging of food supplements and dietary supplements, processed in dedicated and isolated areas authorized by the Ministry of Health.
- Clinical Trial Products (IMP): Production of pilot batches for clinical trials authorized by Regulatory Agencies, including granules, effervescent granules, and specialized liquids. AIFA authorized.
- Storage and Distribution: Warehouse and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements worldwide.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
ITC Farma product offering
Product offeringCore offering
ITC Farma is an Italian pharmaceutical contract manufacturer (CDMO) that produces solid and liquid oral pharmaceutical products, clinical trial materials (IMP), and packaged food supplements on behalf of pharmaceutical multinationals, Italian pharmaceutical companies, and clinical trial sponsors. The company also provides primary and secondary packaging, quality assurance, quality control laboratory services, and worldwide storage and distribution of medicinal products, vaccines, and dietary supplements under EU-GMP Volume 10 and AIFA authorization.
Product overview
ITC Farma is an Italian pharmaceutical company specializing in contract manufacturing (CDMO) for the Italian and multinational market. The portfolio includes Pharma Production for solid and liquid oral drugs, Food Supplements Production, and Clinical Trials (IMP) production. Supporting services include Storage and Distribution, Quality Assurance, and a Quality Control Laboratory. The company operates with EU-GMP Volume 10 standards, AIFA authorization for clinical trials, and Ministry of Health authorization. Production capabilities include tablets (film-coated, non-film-coated, chewable), hard capsules, oral suspensions, solutions, drops, nasal sprays, and inhalation liquids. The company has invested in advanced manufacturing equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, and blister packaging machines with 240 blisters/min capacity, achieving over 30 million packages annually.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharma Production (Contract Manufacturing) Full-service pharmaceutical contract manufacturing including full-cost turn-key production, intermediate supply of tablets or capsules, and primary and secondary packaging for brand and generic medicines. Serves pharmaceutical multinationals and Italian pharmaceutical companies with EU-GMP Volume 10 compliance.
- Food Supplements Production Secondary packaging of food supplements and dietary supplements performed in a dedicated and fully segregated area from pharmaceutical production, authorized by the Ministry of Health. Capable of processing 800 kg of powders per working day.
- Clinical Trials Production (IMP) Production of pilot batches of Investigational Medicinal Products (IMP) for clinical trials, including granules, effervescent granules, and specialized liquids (including hormonal substances). AIFA-authorized for clinical study material production.
- Storage and Distribution Worldwide storage and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements, supporting clients' global supply chain needs.
- Quality Assurance Quality assurance services covering qualification of API and excipient producers, packaging material producers and warehouse suppliers, drafting of quality agreements, process validation protocols, and Product Quality Reviews (PQR).
- Quality Control Laboratory 250 sqm quality control laboratory performing chemical, physical, and microbiological analyses (including Class A sterility tests), development and validation of analytical methods, and ICH-compliant stability studies.
Quantifiable outcome
- Production capacity of over 10 million packages per year
- +5 more outcomes
Companies that use ITC Farma
Customer profileSegments4 records
Ideal customer profiles4 records
ITC Farma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
ITC Farma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IMA ActivecoreLong-standing equipment partnership with IMA Active, a leading manufacturer of pharmaceutical machinery. ITC Farma has acquired multiple pieces of equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018 winner), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, GS 600 coating machine, MYLAB, ROTO CUBE 12, and ROTO MIX 1200. The partnership includes comprehensive technical support, process optimization assistance, and ongoing collaboration for pharmaceutical production excellence. IMA provides process experts who work alongside ITC Farma's internal technologists for continuous improvement.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
ITC Farma competitors and assessment
Company assessmentEmerging players
- Eurofins CDMO: Eurofins' contract development and manufacturing arm, offering API development, solid dose manufacturing and analytical services. Comparable as a contract pharmaceutical manufacturer with GMP-certified oral solid dose capabilities and integrated analytical/QC laboratory services similar to ITC Farma's QC lab offering.
Direct peers
- CordenPharma International: European CDMO (owned by ICIG) offering oral solid dose, sterile injectables, peptides and high-potency manufacturing. Comparable as a European contract manufacturer offering GMP-compliant solid and liquid pharmaceutical production, packaging and clinical trial material supply.
- Fareva: Privately-held French CDMO providing contract development and manufacturing for pharmaceuticals, cosmetics and APIs. Comparable as a privately-owned European CDMO focused on solid/liquid oral dose manufacturing and packaging services for multinational clients.
- Recipharm: Swedish-headquartered European CDMO specializing in oral solid dose, sterile filling and biologics with multiple manufacturing sites. Directly comparable as a mid-sized European CDMO offering contract manufacturing for branded and generic pharmaceuticals, with similar customer segments among Big Pharma clients.
- Idifarma Pharmaceutical Development: Spanish CDMO specialized in oral solid dose development and manufacturing (including high-potency and oncology). Comparable as a mid-sized European CDMO focused on solid oral dosage forms with GMP certification and contract manufacturing services.
- Siegfried Holding: Swiss-listed CDMO providing API and oral solid dose contract manufacturing, with global GMP-certified sites. Comparable mid-to-large CDMO with similar focus on contract manufacturing of finished oral pharmaceuticals for Big Pharma clients.
- Aenova Holding: German-headquartered European CDMO with broad capabilities in oral solid dose, sterile liquids and semi-solids. Comparable mid-sized contract manufacturer serving similar Big Pharma customers with EU-GMP certified facilities for solid/liquid oral pharmaceuticals.
- BSP Pharmaceuticals: Italian CDMO based in Latina (southern Lazio region, near Rome) specializing in GMP contract manufacturing including sterile injectables and biological products. Comparable as an Italian-headquartered CDMO serving pharmaceutical multinationals from a single-cluster location with EU-GMP authorization.
Broad incumbents
- Lonza Group: Swiss-listed global CDMO providing contract development and manufacturing across APIs, biologics, cell and gene therapies, and oral dosage forms. Comparable at a category level as a top-tier global CDMO with EU-GMP certified oral solid dose capabilities, but operates at far greater scale with much broader portfolio and global footprint.
- Catalent: U.S.-headquartered global CDMO providing advanced drug delivery, oral solid dose, biologics and clinical supply services across multiple continents. Comparable at a category level as a leading global CDMO offering oral solid dose contract manufacturing, but operates at vastly greater scale, with broader geographic footprint and portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ITC Farma social profiles
Digital presenceITC Farma compliance and trust
Trust signalCompliance3 records
ITC Farma financial estimates
Financial estimateRevenue estimate
Valuation estimate
ITC Farma leadership team
Management profileNumber of profiles
Profiles8 records
ITC Farma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ITC Farma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ITC Farma
What does ITC Farma do?
ITC Farma is an Italian pharmaceutical contract manufacturer (CDMO) that produces solid and liquid oral pharmaceutical products, clinical trial materials (IMP), and packaged food supplements on behalf of pharmaceutical multinationals, Italian pharmaceutical companies, and clinical trial sponsors. The company also provides primary and secondary packaging, quality assurance, quality control laboratory services, and worldwide storage and distribution of medicinal products, vaccines, and dietary supplements under EU-GMP Volume 10 and AIFA authorization.
Is ITC Farma a public or private company?
ITC Farma is a private company. It is classified as private equity controlled and is currently operating.
When was ITC Farma founded?
ITC Farma was founded in 1960. It employs 51 to 100 people.
Where is ITC Farma based?
ITC Farma is headquartered in Pomezia, Italy, in the Europe region.
How does ITC Farma make money?
Six revenue lines are on record. Contract Manufacturing - Full Cost (Turn-key) is the primary driver. The others are intermediate Products Supply, primary and Secondary Packaging, food Supplements Secondary Packaging, clinical Trial Products (IMP) and storage and Distribution.
Who are ITC Farma's main competitors?
Eurofins CDMO is listed as an emerging player. Direct peers are CordenPharma International, Fareva, Recipharm, Idifarma Pharmaceutical Development, Siegfried Holding, Aenova Holding and BSP Pharmaceuticals. Broad incumbents are Lonza Group and Catalent.
Does ITC Farma have an API?
No public API is recorded for ITC Farma.
What industry is ITC Farma in?
ITC Farma's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its SIC code is 8731.